Director/PDMR Shareholding
On September 22, 2025, Stephen O'Hara, a Director at OptiBiotix Health PLC, purchased 100,000 ordinary shares at a price of 9.77 pence per share in London. Subsequently, on September 23, 2025, O'Hara made a further purchase of 95,238 ordinary shares at 10.5 pence per share, also in London. In aggregate, Stephen O'Hara purchased 195,238 shares at an aggregated purchase price of 10.13 pence, resulting in a resultant interest of 10,408,224 ordinary shares, representing 10.08% of the issued ordinary shares.
Select text to share a quote on X · sign in to keep highlights & notes in your OPTI notes
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitutes, announces that the Company has been informed that Stephen O'Hara, a Director of the Company, made the following purchases of ordinary shares in the capital of the Company. Further details are set out in the Notification of Dealing Form below.
| Director | Purchase price (Aggregated) | Ordinary shares purchased | Resultant interest in ordinary shares | Resultant percentage of issued ordinary shares |
| Stephen O'Hara | 10.13 pence | 195,238 | 10,408,224 | 10.08% |
| a. | Name | Stephen O'Hara | ||
| 2 | Reason for notification | |||
| a. | Position/Status | Director - Chief Executive Officer | ||
| b. | Initial notification/ Amendment | Initial Notification | ||
| a. | Name | OptiBiotix Health Plc | ||
| b. | LEI | |||
| a. | Description of the financial instrument, type of instrument Identification Code | Ordinary shares of 2p each ISIN: GB00BP0RTP38 | ||
| b. | Nature of the transaction | Purchase of ordinary shares | ||
| c. | Price(s) and volume(s) | |||
| Price(s) per share | Volume(s) | |||
| 9.77p | 50,000 | |||
| 9.78p | 50,000 | |||
| d. | Aggregated information - Volume - Price | 100,000 shares 9.77 pence per share | ||
| f. | Place of the transaction | London |
Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |
| a. | Name | Stephen O'Hara |
| 2 | Reason for notification | |
| a. | Position/Status | Director - Chief Executive Officer |
| b. | Initial notification/ Amendment | Initial Notification |
| a. | Name | OptiBiotix Health Plc |
| b. | LEI | |
| a. | Description of the financial instrument, type of instrument Identification Code | Ordinary shares of 2p each ISIN: GB00BP0RTP38 |
| b. | Nature of the transaction | Purchase of ordinary shares |
| c. | Price(s) and volume(s) | |
| Price(s) per share | Volume(s) | |
| 10.5p | 47,619 | |
| 10.5p | 47,619 | |
| d. | Aggregated information - Volume - Price | 95,238 shares 10.5 pence per share |
| f. | Place of the transaction | London |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.